Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio Total Liabilities (Quarterly) : 20.72M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.72M |
| March 31, 2026 | 24.71M |
| December 31, 2025 | 43.53M |
| September 30, 2025 | 43.04M |
| June 30, 2025 | 40.94M |
| March 31, 2025 | 39.30M |
| December 31, 2024 | 41.15M |
| September 30, 2024 | 39.04M |
| June 30, 2024 | 34.84M |
| March 31, 2024 | 35.65M |
| December 31, 2023 | 39.26M |
| September 30, 2023 | 42.98M |
| June 30, 2023 | 43.28M |
| March 31, 2023 | 42.89M |
| December 31, 2022 | 42.18M |
| September 30, 2022 | 45.66M |
| Date | Value |
|---|---|
| June 30, 2022 | 51.37M |
| March 31, 2022 | 51.91M |
| December 31, 2021 | 36.42M |
| September 30, 2021 | 28.71M |
| June 30, 2021 | 37.26M |
| March 31, 2021 | 23.67M |
| December 31, 2020 | 23.29M |
| September 30, 2020 | 19.79M |
| June 30, 2020 | 14.70M |
| March 31, 2020 | 5.761M |
| December 31, 2019 | 4.261M |
| September 30, 2019 | 2.468M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 2.516M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 236.98M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.18M |
| Shareholders Equity (Quarterly) | 4.456M |
| Current Ratio | 1.215 |
| Net Debt Paydown Yield | 31.99% |